Pineapple, Inc. Stock: price and insider trades · United States

PINEAPPLE, INC. (ticker: PNPL) is a United States-listed company whose public filings and press releases have historically placed it in the cannabis-adjacent and specialty consumer/wellness space, with a more recent effort to diversify beyond its original niche. The company has communicated from Los Angeles, California, which remains its principal geographic reference point in the public record. For French-speaking investors in France, Belgium, and Switzerland, PNPL should be viewed as a small-cap U.S. story with a relatively limited disclosure footprint compared with larger NYSE or NASDAQ names, and with a business profile that has evolved over time. Public materials indicate that Pineapple originally built its business around non-plant-touching cannabis activities, including leasing property to licensed cannabis operators, offering hemp-derived CBD products through online and in-store channels, and providing cannabis business licensing and consulting services. It also referenced related management and intellectual-property activities within its broader portfolio. More recently, the company said it was expanding into functional mushroom products under the Shroomtropics brand and into cannabis retail management, signaling a move toward branded consumer products and service-led revenue streams. That shift suggests an attempt to move up the value chain toward higher-margin, potentially more recurring businesses rather than capital-intensive operations. From a competitive standpoint, Pineapple operates in fragmented, highly regulated markets where differentiation depends on execution speed, brand creation, licensing capability, and partnership structures rather than scale advantages. The company’s recent updates in 2025 emphasized strategic expansion, including the launch of functional mushroom products and a push into retail management services, both framed as drivers of longer-term growth and profitability. In practical terms, PNPL remains an event-driven and speculative equity, where investor focus tends to center on strategic announcements, regulatory developments, and operating execution. It is therefore best understood as a higher-risk U.S. micro/small-cap situation rather than a mature consumer staple or industrial platform listed on NYSE/NASDAQ in the United States.